✦ LIBER ✦

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

✍ Scribed by Jin, J; Jiang, D-Z; Mai, W-Y; Meng, H-T; Qian, W-B; Tong, H-Y; Huang, J; Mao, L-P; Tong, Y; Wang, L

Book ID: 110056805
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 123 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404287

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose homoharringtonine and cytarabin

Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia

✍ Chen, Chen; Xu, Wei; Yang, Jing 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 341 KB

CTLA-4 genotype and relapse incidence in

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

✍ Pérez-García, A; Brunet, S; Berlanga, J J; Tormo, M; Nomdedeu, J; Guardia, R; Ri 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 157 KB

High-dose cytarabine induction is well t

High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years

✍ Martha Arellano; Elliott Winton; Lin Pan; Lisa Lima; Mourad Tighiouart; Kapil Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

The prognostic significance of leukemic

The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia

✍ Zhijian Xiao; Hua Xue; Rui Li; Li Zhang; Minghua Yu; Yushu Hao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

A scoring system to predict the risk of

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

✍ David Valcárcel; Pau Montesinos; Isabel Sánchez-Ortega; Salut Brunet; Jordi Este 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou

Reduced-intensity cord blood transplanta

Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation

✍ Toshimitsu Ueki; Masahiko Sumi; Keijiro Sato; Ikuo Shimizu; Daigo Akahane; Mayum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB